Bulk ingredients

(Image: BernardaSv)

AMRI awarded seven-year NIH contract

By Melissa Fassbender

AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.

(Image: WuXi AppTec Co., Ltd.)

WuXi AppTec IPO tops $353m

By Melissa Fassbender

The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

Follow us

Product Innovations

Validating The Simoa Technology

Validating The Simoa Technology

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...